Published in Nature on May 24, 1990
Progression to AIDS in the absence of a gene for vpr or vpx. J Virol (1995) 3.96
Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J (1992) 3.25
Species-specific diversity among simian immunodeficiency viruses from African green monkeys. J Virol (1991) 2.70
Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J Virol (1994) 2.29
Worldwide prevalence of lentivirus infection in wild feline species: epidemiologic and phylogenetic aspects. J Virol (1992) 1.93
Wild primate populations in emerging infectious disease research: the missing link? Emerg Infect Dis (1998) 1.91
Structural features in TAR RNA of human and simian immunodeficiency viruses: a phylogenetic analysis. Nucleic Acids Res (1992) 1.74
A lion lentivirus related to feline immunodeficiency virus: epidemiologic and phylogenetic aspects. J Virol (1994) 1.56
A highly divergent simian immunodeficiency virus (SIVstm) recovered from stored stump-tailed macaque tissues. J Virol (1991) 0.99
Neuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS. J Neurovirol (2008) 0.91
Defect of human immunodeficiency virus type 2 Gag assembly in Saccharomyces cerevisiae. J Virol (2007) 0.84
Seroprevalence of simian immunodeficiency virus in wild and captive born Sykes' monkeys (Cercopithecus mitis) in Kenya. Retrovirology (2004) 0.82
Tropical medicine. Postgrad Med J (1991) 0.77
Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature (1990) 5.02
Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell (1991) 13.69
Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science (1998) 12.81
Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature (2000) 9.80
Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science (1992) 9.30
Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science (1985) 9.27
Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med (1995) 8.15
Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature (1987) 7.96
Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science (1985) 6.02
The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res Hum Retroviruses (1990) 5.79
A role for carbohydrates in immune evasion in AIDS. Nat Med (1998) 5.06
Progression to AIDS in the absence of a gene for vpr or vpx. J Virol (1995) 3.96
Four novel U RNAs are encoded by a herpesvirus. Cell (1988) 3.86
Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol (1996) 3.84
Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. Science (1985) 3.74
Significance of premature stop codons in env of simian immunodeficiency virus. J Virol (1989) 3.60
Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. J Virol (1991) 3.46
Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J Virol (2001) 3.40
Methylation of Herpesvirus saimiri DNA in lymphoid tumor cell lines. Proc Natl Acad Sci U S A (1979) 3.24
Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus. J Gen Virol (1987) 3.18
Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J Virol (1992) 3.16
Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus. Nat Med (1997) 3.11
The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses. Arch Virol (1992) 3.09
Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell (1995) 3.03
Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc Natl Acad Sci U S A (1992) 2.94
Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus. J Virol (1997) 2.90
Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes. AIDS Res Hum Retroviruses (1994) 2.72
Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry. J Virol (1993) 2.70
Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation. J Virol (1999) 2.69
Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys. J Virol (1993) 2.65
Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J Virol (1999) 2.65
Titration and characterization of two rhesus-derived SIVmac challenge stocks. AIDS Res Hum Retroviruses (1994) 2.63
High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J Virol (1996) 2.61
Viral-encoded small RNAs in herpes virus saimiri induced tumors. EMBO J (1986) 2.60
Comparison of simian immunodeficiency virus isolates. Nature (1988) 2.55
Nononcogenic deletion mutants of herpesvirus saimiri are defective for in vitro immortalization. J Virol (1986) 2.52
A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation. J Virol (1997) 2.41
Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat Med (1998) 2.38
Cellular localization of simian immunodeficiency virus in lymphoid tissues. I. Immunohistochemistry and electron microscopy. Am J Pathol (1989) 2.33
Deletion mutants of herpesvirus saimiri define an open reading frame necessary for transformation. J Virol (1989) 2.29
The divergence between two oncogenic Herpesvirus saimiri strains in a genomic region related to the transforming phenotype. Virology (1990) 2.28
Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. J Virol (1997) 2.27
Classification of herpesvirus saimiri into three groups based on extreme variation in a DNA region required for oncogenicity. J Virol (1984) 2.25
A region of the Herpesvirus saimiri genome required for oncogenicity. Science (1985) 2.22
A new type D retrovirus isolated from macaques with an immunodeficiency syndrome. Science (1984) 2.22
Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. AIDS Res Hum Retroviruses (1994) 2.18
Identification of transforming genes of subgroup A and C strains of Herpesvirus saimiri. Proc Natl Acad Sci U S A (1991) 2.18
The primary sequence of rhesus monkey rhadinovirus isolate 26-95: sequence similarities to Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus isolate 17577. J Virol (2000) 2.15
Deletion of DNA sequence in a nononcogenic variant of Herpesvirus saimiri. J Virol (1984) 2.14
Herpesvirus saimiri DNA in a lymphoid cell line established by in vitro transformation. J Virol (1984) 2.09
Virus-encoded cyclin. Mol Cell Biol (1994) 2.06
Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J Virol (2000) 2.04
The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1992) 2.00
Characterization of Novikoff hepatoma mRNA methylation and heterogeneity in the methylated 5' terminus. Biochemistry (1975) 1.96
Protective immunity induced by live attenuated simian immunodeficiency virus. Curr Opin Immunol (1998) 1.90
Construction of replication-competent Herpesvirus saimiri deletion mutants. J Virol (1984) 1.89
Identification and characterization of the herpesvirus saimiri oncoprotein STP-C488. J Virol (1991) 1.84
Herpesvirus saimiri strain variability. J Virol (1982) 1.80
Analysis of simian immunodeficiency virus sequence variation in tissues of rhesus macaques with simian AIDS. J Virol (1993) 1.77
Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in vivo in the absence of an intact nef gene. J Virol (1994) 1.77
Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. J Virol (1997) 1.71
Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: evidence for cross-species transmission in the wild. J Virol (1994) 1.70
A caution on the use of SIV/HIV gag antigen detection systems in neutralization assays. AIDS Res Hum Retroviruses (1992) 1.70
Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1. N Engl J Med (1999) 1.69
Association of the viral oncoprotein STP-C488 with cellular ras. Mol Cell Biol (1995) 1.66
Sexual transmission of SIVagm in wild grivet monkeys. J Med Primatol (1994) 1.63
Simian immunodeficiency virus-induced meningoencephalitis: natural history and retrospective study. Ann Neurol (1988) 1.63
Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophages. J Virol (2000) 1.57
Herpesvirus saimiri DNA in tumor cells--deleted sequences and sequence rearrangements. J Virol (1981) 1.55
Lymphadenopathy in macaques experimentally infected with the simian immunodeficiency virus (SIV). Am J Pathol (1987) 1.54
Cellular localization of simian immunodeficiency virus in lymphoid tissues. II. In situ hybridization. Am J Pathol (1989) 1.52
A gene for dihydrofolate reductase in a herpesvirus. Science (1988) 1.47
Induction of AIDS in rhesus monkeys by a recombinant simian immunodeficiency virus expressing nef of human immunodeficiency virus type 1. J Virol (1999) 1.47
Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus. J Virol (2000) 1.47
Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry. Virology (1993) 1.45
STP and Tip are essential for herpesvirus saimiri oncogenicity. J Virol (1998) 1.45
AIDS biosafety. Science (1991) 1.44
Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence. Curr Top Microbiol Immunol (1994) 1.43
Identification of Lck-binding elements in tip of herpesvirus saimiri. J Biol Chem (1995) 1.43
Humoral immune responses to T cell tropic retrovirus simian T lymphotropic virus type III in monkeys with experimentally induced acquired immune deficiency-like syndrome. J Clin Invest (1986) 1.43
Identification and characterization of Kaposi's sarcoma-associated herpesvirus K8.1 virion glycoprotein. J Virol (1999) 1.42
Direct demonstration of retroviral recombination in a rhesus monkey. J Virol (1997) 1.41
Experimental infection of rhesus and pig-tailed macaques with macaque rhadinoviruses. J Virol (1999) 1.41
The "V3" domain is a determinant of simian immunodeficiency virus cell tropism. J Virol (1994) 1.40
Early regeneration of thymic progenitors in rhesus macaques infected with simian immunodeficiency virus. J Exp Med (1998) 1.39
Efficient transcription and replication of simian immunodeficiency virus in the absence of NF-kappaB and Sp1 binding elements. J Virol (1996) 1.39
Extensive genetic variability of simian immunodeficiency virus from African green monkeys. J Virol (1989) 1.37
The role of upstream U3 sequences in the pathogenesis of simian immunodeficiency virus-induced AIDS in rhesus monkeys. J Virol (1994) 1.36
Zeta chain of the T-cell receptor interacts with nef of simian immunodeficiency virus and human immunodeficiency virus type 2. J Virol (1998) 1.31
Specifically unmethylated cytidylic-guanylate sites in Herpesvirus saimiri DNA in tumor cells. J Virol (1982) 1.29
Comparative biology of natural and experimental SIVmac infection in macaque monkeys: a review. J Med Primatol (1990) 1.29
High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection. AIDS Res Hum Retroviruses (1994) 1.26
Effects of natural sequence variation on recognition by monoclonal antibodies neutralize simian immunodeficiency virus infectivity. J Virol (1994) 1.25
Recombinant simian immunodeficiency virus expressing green fluorescent protein identifies infected cells in rhesus monkeys. AIDS Res Hum Retroviruses (1999) 1.24
Prevalence of antibodies to SIV in baboons in their native habitat. AIDS Res Hum Retroviruses (1989) 1.23
Induction of lymphocyte proliferation and severe gastrointestinal disease in macaques by a nef gene variant SIVmac239. Am J Pathol (1996) 1.22
Characterization of monoclonal antibodies that distinguish simian immunodeficiency virus isolates from each other and from human immunodeficiency virus types 1 and 2. J Gen Virol (1990) 1.22